youtube_live
Q1 2026 earnings • released • EPS miss -6.06%
See resultschevron_right
MOLN:SWX
Molecular Partners AG
CHF 3.12
arrow_upward
+4.00%(+0.12) 1D
Jun 3, 5:31:23 PM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOLN...
Open
CHF 3.05
High
CHF 3.12
Low
CHF 3.05
Mkt. cap
125.97M
Avg. vol.
27.89K
Volume
14.44K
52-wk high
CHF 3.96
52-wk low
CHF 2.66
EPS
-CHF 1.57
Shares outstanding
40.37M
No. of employees
134
Open
CHF 3.05
High
CHF 3.12
Low
CHF 3.05
Mkt. cap
125.97M
Avg. vol.
27.89K
Volume
14.44K
52-wk high
CHF 3.96
52-wk low
CHF 2.66
EPS
-CHF 1.57
Shares outstanding
40.37M
No. of employees
134
News stories
From sources across the web
www.marketscreener.com
·
21 minutes ago
MetaOptics On Track for Nasdaq Listing; Shares Down 3%
The Motley Fool
·
1 hour ago
The S&P 500 Index Has Only Traded at This High a Valuation 1 Other Time in Its 69-Year Existence. History Couldn't Be Any Clearer on What Happens Next.
巴士的報
·
1 hour ago
U.S. stocks retreat as Middle East tensions persist
Investor's Business Daily
·
1 hour ago
Futures: SpaceX Sets IPO Price Target; Two AI Giants Dive Late
Profile
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
About Molecular Partners AG
AI content may include mistakes. Learn more